跳至主要内容
临床试验/IRCT20150119020715N10
IRCT20150119020715N10招募中3 期

Evaluation of the effect of oral livergol on liver enzymes in patients with Leukemia in the Preservative Phase

Arak University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 no limit(—)
性别
All

入选标准

  • Patients over 5 years of age with leukemia in the preservative phase referring to Amir Kabir hospital in Arak
  • Informed consent of the participants in the study
  • Disrupted liver enzymes (AST and ALT greater than 60).
  • Total cholesterol above 200
  • Total bilirubin equal to or greater than 2
  • GGT more than 60

排除标准

  • With other blood diseases and liver diseases such as HBV, HCV and HIV

研究者

相似试验